The effect of N -acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections

Bjarnsholt, 2013, The role of bacterial biofilms in chronic infections, APMIS, 121, 1, 10.1111/apm.12099 Lebeaux, 2014, Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics, Microbiol. Mol. Biol. Rev., 78, 510, 10.1128/MMBR.00013-14 Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discov., 2, 114, 10.1038/nrd1008 Gil-Perotin, 2012, Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept, Crit. Care, 10.1186/cc11357 Mietto, 2013, Ventilator associated pneumonia: evolving definitions and preventive strategies, Respir. Care, 58, 990, 10.4187/respcare.02380 Safdar, 2005, The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention, Respir. Care, 50 Koch, 1993, Pathogenesis of cystic fibrosis, Lancet, 341, 1065, 10.1016/0140-6736(93)92422-P Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 Ciofu, 2015, Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients, Adv. Drug Deliv. Rev., 85, 7, 10.1016/j.addr.2014.11.017 Hassett, 2014, Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives, J. Microbiol., 52, 211 Eldika, 2006, Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease, Curr. Opin. Pulm. Med., 12, 118, 10.1097/01.mcp.0000208451.50231.8f Martínez-Solano, 2008, Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease, Clin. Infect. Dis., 10.1086/593186 Chalmers, 2013, Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis, Mol. Immunol., 55, 27, 10.1016/j.molimm.2012.09.011 Marsh, 2014, Detection of biofilm in bronchoalveolar lavage from children with non-cystic fibrosis bronchiectasis, Pediatr. Pulmonol. Chalmers, 2015, Management of bronchiectasis in adults, Eur. Respir. J., 45, 1446, 10.1183/09031936.00119114 Tunney, 2013, Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation, Am. J. Respir. Crit. Care Med., 187, 1118, 10.1164/rccm.201210-1937OC Rogers, 2014, Predominant pathogen comptetition and core microbiota divergence in chronic airway infection, ISME J., 9, 217, 10.1038/ismej.2014.124 Priftis, 2013, Bacterial bronchitis caused by Streptococcus pneumoniae and nontypable Haemophilus influenzae in children: the impact of vaccination, Chest, 143, 152, 10.1378/chest.12-0623 Hamilos, 2014, Host-microbial interactions in patients with chronic rhinosinusitis, J. Allergy Clin. Immunol., 133, 640, 10.1016/j.jaci.2013.06.049 Hall-Stoodley, 2006, Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media, JAMA, 10.1001/jama.296.2.202 Bakaletz, 2012, Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media, Paediatr. Respir. Rev., 13, 154, 10.1016/j.prrv.2012.03.001 Foreman, 2009, Characterization of bacterial and fungal biofilms in chronic rhinosinusitis, Am. J. Rhinol. Allergy, 23, 556, 10.2500/ajra.2009.23.3413 Conlon, 2013, Activated ClpP kills persisters and eradicates a chronic biofilm infection, Nature, 503, 365, 10.1038/nature12790 Stewart, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 Fux, 2005, Survival strategies of infectious biofilms, Trends Microbiol., 13, 34, 10.1016/j.tim.2004.11.010 Chavez-Dozal, 2014, In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation, Antimicrob. Agents Chemother., 58, 5855, 10.1128/AAC.03137-14 Bryers, 2006, Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo, Biomaterials, 27, 5039, 10.1016/j.biomaterials.2006.05.034 Roveta, 2004, Confronto tra gli effetti di N-acetil-cisteina, Ambroxol, Bromexina e Sobrerolo sui biofilm di Staphylococcus aureus, GIMMOC, 8, 131 Pérez-Giraldo, 1997, Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis, JAC, 39, 643, 10.1093/jac/39.5.643 El-Feky, 2009, Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces, Pol. J. Microbiol., 58, 261 Marchese, 2003, Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms, Int. J. Antimicrob. Agents, 22, 95, 10.1016/S0924-8579(03)00232-2 Mohsen, 2015, Antibacterial, anti-biofilm activity of some non-steroidal anti-inflammatory drugs and N-acetyl cysteine against some biofilm producing uropathogens, Am. J. Epidemiol. Infect. Dis., 3, 1 Aslam, 2011, Role of antibiofilm-antimicrobial agents in controlling device-related infections, Int. J. Artif. Organs, 34, 752, 10.5301/ijao.5000024 Aslam, 2007, Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters, Antimicrob. Agents Chemother., 51, 1556, 10.1128/AAC.00893-06 Olofsson, 2003, N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces, Appl. Environ. Microbiol., 69, 4814, 10.1128/AEM.69.8.4814-4822.2003 Lea, 2014, In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media, J. Otolaryngol. Head. Neck Surg., 7, 20, 10.1186/1916-0216-43-20 Drago, 2013, Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials, Int. J. Artif. Organs, 36, 39, 10.5301/ijao.5000135 Zhao, 2010, N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa, BMC Microbiol., 12, 140, 10.1186/1471-2180-10-140 Moon, 2015, In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia, J. Microbiol., 53, 321 Roveta, 2004, Comparison of the activity of N-acetylcysteine, ambroxol, bromexine and sobrerol on Staphylococcus aureus biofilms, GIMMOC, 8, 12 Bozzolasco, 2002, Rilevanza dei biofilm batterici nelle infezioni respiratorie: problematiche terapeutiche e possibili soluzioni, GIMMOC, VI, 203 Leite, 2013, Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms, Enferm. Infecc. Microbiol. Clin., 31, 655, 10.1016/j.eimc.2012.11.011 Kirmusaoğlu, 2012, The effect of N-acetylcysteine on growth and biofilm formation in Staphylococcus epidermidis strains, Turk J. Med. Sci., 42, 689 Gomes, 2012, Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells, Braz. J. Microbiol., 43, 235, 10.1590/S1517-83822012000100026 Venkatesh, 2009, Novel synergistic antibiofilm combinations for salvage of infected catheters, J. Med. Microbiol., 58, 936, 10.1099/jmm.0.009761-0 Quah, 2012, N-acetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis, J. Endod., 38, 81 El-Baky, 2014, N-acetylcysteine inhibits and eradicates Candida albicans biofilms, Am. J. Infect. Dis. Microbiol., 2, 122 Kashef, 2015, Phototoxic effect of hypericin alone and in combination with acetylcysteine on Staphylococcus aureus biofilms, Photodiagnosis Photodyn. Ther., 12, 186, 10.1016/j.pdpdt.2015.04.001 Del Prado, 2010, Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetylcysteine, amoxicillin, erythromycin, and levofloxacin, Diagn. Microbiol. Infect. Dis., 67, 311, 10.1016/j.diagmicrobio.2010.03.016 Riise, 2000, Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro, Respiration, 67, 552, 10.1159/000067473 Zheng, 1999, The effects of S-carboxymethylcysteine and N-acetylcysteine on the adherence of Moraxella catarrhalis to human pharyngeal epithelial cells, Microbiol. Immunol., 43, 107, 10.1111/j.1348-0421.1999.tb02381.x Olofsson, 2005, Use of a quartz crystal microbalance to investigate the antiadhesive potential of N-acetyl-L-cysteine, Appl. Environ. Microbiol., 71, 2705, 10.1128/AEM.71.5.2705-2712.2005 Tam, 2013, Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis, Cochrane Database Syst. Rev., 7, CD007168 Skov, 2015, The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection – a pilot study, J. Cyst. Fibros., 14, 211, 10.1016/j.jcf.2014.09.015 Conrad, 2015, Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial, J. Cyst. Fibros., 14, 219, 10.1016/j.jcf.2014.08.008 Cazzola, 2015, Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis, Eur. Respir. Rev., 24, 451, 10.1183/16000617.00002215 Tse, 2013, High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study, Chest, 144, 106, 10.1378/chest.12-2357 Dekhuijzen, 2004, Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease, Eur. Respir. J., 23, 629, 10.1183/09031936.04.00016804 R1, 2005, High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease, Clin. Drug Investig., 25, 401, 10.2165/00044011-200525060-00005 Grassi, 2002, Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate, J. Chemother., 14, 279, 10.1179/joc.2002.14.3.279 Hill, 2012, British Thoracic Society national bronchiectasis audit 2010 and 2011, Thorax, 67, 928, 10.1136/thoraxjnl-2012-201983 Serra, 2007, A therapeutic approach in the treatment of infections of the upper airways: thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route), Int. J. Immunopathol. Pharmacol., 20, 607, 10.1177/039463200702000319 Macchi, 2012, Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid therapy, Int. J. Immunopathol. Pharmacol., 25, 207, 10.1177/039463201202500123 Smith, 2011, Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment, Otolaryngol. Head. Neck Surg., 144, 338, 10.1177/0194599810391620